Outpatient CD19-directed CAR T-cell therapy is feasible in patients of all ages.

The data that support the findings of this study are available from the corresponding author upon reasonable request. Figure S1. Figure S2. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.